In-house counsel at pharmaceutical, medical device, and health companies are invited to join their peers and leading Reed Smith life sciences lawyers for a roundtable discussion on how to identify and mitigate risk. The event will be held on 5 March in Reed Smith’s London office. A networking breakfast will be provided at 8:30 a.m., with the program itself starting at 9 a.m. and ending at 11:30 a.m.
Panels will cover “The Intersection of Digital Health and Data Protection: Devices, Data Collection and Analytics and Control,” “Patents: A Discussion of What Keeps the In-House Practitioner Awake at Night,” and “Global Investigations of Companies and their People: A Look at Current Issues through the Lens of a Case Study.”
We are pleased to welcome several in-house and industry speakers, including Helen Barraclough (Associate General Counsel, Smith & Nephew), Andrew Davies (Director, Market Access, Association of British HealthTech Industries), Alexander Povey (Consultant Patent Attorney, MSD), and Brooke Daley (Investigations and Compliance Counsel, Zimmer Biomet).